CING Reports $30M Cash, FDA CRL for CTx-1301 ADHD Drug No Safety Issues, CMC Requests Only
Cingulate Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.60
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS